AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Determination of Sensitivity and Specificity of Straight Leg Raise Test Via Transforaminal Nerve Root Block

Recruitingn/aAges 18 Years - 65 YearsAllMarmara University
💬

In plain words

What the trial is, and whether it could suit you

This study aims to evaluate the diagnostic accuracy of the straight leg raise test in patients with suspected lumbosacral radicular pain. Lumbosacral radicular pain is often caused by lumbar disc herniation and may radiate from the lower back or buttock to the leg. Although the straight leg raise test is commonly used in clinical practice, its diagnostic performance has been reported to vary. In this study, diagnostic transforaminal epidural steroid injection or selective nerve root block will be used as the reference standard. The sensitivity, specificity, likelihood ratios, and area under the curve of the straight leg raise test will be calculated. The findings may help guide clinicians in determining when the straight leg raise test is sufficient and when further diagnostic confirmation may be needed.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Age between 18 and 65 years. * Preliminary diagnosis of lumbar radicular pain based on medical history, physical examination, and lumbar magnetic resonance imaging. * Patients scheduled to undergo transforaminal epidural injection targeting the L4, L5, or S1 nerve root. Exclusion Criteria: * Inability to access clinical or procedural records in the hospital system. * Absence of available radiological records related to the target level, if required. * Inability to provide reliable NRS or straight leg raise test assessment due to cognitive impairment or language barrier. * Coagulopathy, defined as INR \> 1.5 or platelet count \< 80,000/mm³, or inability to discontinue anticoagulant or antiplatelet therapy when required. * Local or systemic infection, or skin lesion at the planned injection site. * Pregnancy or breastfeeding. * Known severe hypersensitivity to iodinated contrast material or local anesthetics. * Progressive neurological deficit or cauda equina syndrome. * Bilateral or nearly bilateral pain with both sides being prominent and equivalent, or need for therapeutic injection at more than one level during the same session. * Epidural injection with local anesthetic and/or steroid at the same level within the last 6 weeks. * Active polyneuropathy or other diffuse neuropathies. * Active radicular pain originating from nerve roots other than L4, L5, or S1. * Requirement for mandatory sedation.
💊

What it tests

  • Not listed
📍

Where

1 site
Marmara University Faculty of Medicine, Pendik Training and Research Hospital, Algology Department Recruiting
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy